title: [Isoflurane-induced malignant hyperthermia during intensive-care treatment].
abstract: Malignant hyperthermia (MH), an inherited myopathia varying in severity and course, is induced by halogenated anesthetic agents and depolarizing muscle relaxants. First recognized as a distinct disease entity in 1960, MH is defined as an anesthesia-related disease due to the agents by which it is triggered. Given the wide use of these preparations in prehospital emergency medicine and intensive care treatment, physicians in other disciplines may also encounter MH.
authors.affiliation: Klinik für Anästhesie, operative Intensivmedizin und Schmerztherapie, Helios St. Johannes Klinik Duisburg, An der Abtei 7-11, 47166, Duisburg, Deutschland.
authors.forename: B
authors.initials: B
authors.lastname: Wendlandt
authors.forename: S
authors.initials: S
authors.lastname: Turinsky
authors.forename: M
authors.initials: M
authors.lastname: Schmitz
mesh_terms: D000280:Administration, Inhalation; D016887:Cardiopulmonary Resuscitation; D003131:Combined Modality Therapy; D016292:Procedural Sedation; D004554:Electric Countershock; D006336:Heart Massage; D006801:Humans; D007036:Hypothermia, Induced; D007362:Intensive Care Units; D007530:Isoflurane / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008305:Malignant Hyperthermia / Q000209:etiology*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D015912:Thrombolytic Therapy
chemical_list: D007530:Isoflurane